1. Home
  2. IQV vs ZTS Comparison

IQV vs ZTS Comparison

Compare IQV & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

HOLD

Current Price

$203.92

Market Cap

34.6B

Sector

Health Care

ML Signal

HOLD

Logo Zoetis Inc.

ZTS

Zoetis Inc.

HOLD

Current Price

$75.05

Market Cap

31.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IQV
ZTS
Founded
1982
1952
Country
United States
United States
Employees
93000
N/A
Industry
Biotechnology: Commercial Physical & Biological Resarch
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.6B
31.9B
IPO Year
2013
2012

Fundamental Metrics

Financial Performance
Metric
IQV
ZTS
Price
$203.92
$75.05
Analyst Decision
Strong Buy
Buy
Analyst Count
16
12
Target Price
$227.13
$154.18
AVG Volume (30 Days)
1.5M
5.3M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
1.86%
EPS Growth
4.67
10.05
EPS
1.61
1.42
Revenue
$9,739,000,000.00
$9,467,000,000.00
Revenue This Year
$6.77
$5.63
Revenue Next Year
$5.89
$4.77
P/E Ratio
$129.54
$53.77
Revenue Growth
41.60
2.28
52 Week Low
$154.50
$71.47
52 Week High
$247.05
$161.77

Technical Indicators

Market Signals
Indicator
IQV
ZTS
Relative Strength Index (RSI) 66.57 40.73
Support Level $159.91 $73.39
Resistance Level $209.48 $82.66
Average True Range (ATR) 7.02 2.39
MACD 2.45 0.50
Stochastic Oscillator 84.77 43.04

Price Performance

Historical Comparison
IQV
ZTS

About IQV IQVIA Holdings Inc.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

About ZTS Zoetis Inc.

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Share on Social Networks: